Search - tctmd.com

Displaying 41 - 60 of 448

Sort: Relevancy | Date

News Industry News

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

June 12, 2025

News Conference News CRT 2025

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

L.A. McKeown

March 10, 2025

News Daily News

Top Endovascular News of 2024

L.A. McKeown

December 28, 2024

News Daily News

Top Coronary Artery Disease News in 2024

Michael O'Riordan

December 26, 2024

News Features

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Todd Neale

December 19, 2024

News Conference News VIVA 2024

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

L.A. McKeown

November 05, 2024

Presentation TCT 2024

TCT 1248: Drug-Coated Balloon Alone Strategy to Avoid Multiple Stenting in a Patient With High Bleeding Risk

Presenter: Marco Luciano Rossi

October 30, 2024

Presentation TCT 2024

A Hybrid Approach With Stents and Drug Coated Balloons: Mainstream or Niche?

Presenter: Ricardo Costa

October 30, 2024

News Conference News TCT 2024

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

L.A. McKeown

October 29, 2024

Presentation TCT 2024

TCT 495: The Impact of Cutting Balloon Pre-Dilation on the Outcomes of Paclitaxel Drug-Coated Balloon Treatment for Coronary In-Stent Restenosis

Presenter: Yuanji Ma

October 29, 2024

Presentation TCT 2024

TCT 496: Long-term Clinical Outcomes of Drug-Coated Balloons for the Treatment of In-Stent Chronic Total Occlusions

Presenter: Jiasheng Yin

October 29, 2024

Presentation TCT 2024

TCT 493: Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials

Presenter: Michael Sabina

October 29, 2024

Presentation TCT 2024

TCT 1322: Neoatherosclerosis After Drug-Coated Balloon Treated In-Stent Restenosis

Presenter: Leonardo Sinnott Silva

October 29, 2024

Presentation TCT 2024

TCT 315: Acute and Long-Term Safety and Efficacy of IVUS-Guided Drug Coated Balloon Treatment for Carotid In-Stent Restenosis

Presenter: Piero Montorsi

October 29, 2024

Presentation TCT 2024

TCT 569: Outcomes of Patients With Left Main Lesions Treated With Hybrid Drug-eluting Stent and Drug-coated Balloon Strategy

Presenter: Nancy Virginia

October 29, 2024

News Conference News TCT 2024

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

Caitlin E. Cox

October 28, 2024

Presentation TCT 2024

TCT 39: Comparison of Clinical Outcomes Among Balloon Angioplasty, Drug-Coated Balloon, and the Second or Newer Drug-Eluting Stent

Presenter: Yuko Kiyohara

October 28, 2024

Presentation TCT 2024

TCT 568: Drug-Coated Balloon Versus Non-Compliant Balloon Angioplasties for Side Branch After Main Vessel Stenting for True Coronary Bifurcation Lesions: The Prospective, Multicenter, Randomized, Blinded DCB-BIF Trial

Presenter: NULL

October 28, 2024

Presentation TCT 2024

TCT 441: Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: A Systematic Review and Meta-Analysis

Presenter: Denise Pellegrini

October 28, 2024

Presentation TCT 2024

TCT 442: Tissue Characteristics Can Predict Clinical Outcome in Stent-Less Percutaneous Coronary Intervention With Directional Coronary Atherectomy Followed by Drug-Coated Balloon: Insights From a Histological Analysis

Presenter: Gaku Nakazawa

October 28, 2024

Advertisement

Fondazione Ricerca e Innovazione Cardiovascolare Completes Enrollment in TRANSFORM II RCT, A landmark study comparing MagicTouch SCB vs DES in Native Coronary Vessels

AGENT IDE: DCB Performance for In-Stent Restenosis Lasts Out to 2 Years

Top Endovascular News of 2024

Top Coronary Artery Disease News in 2024

Reimbursement Issues Seem to Be Holding Renal Denervation Back

Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK

TCT 1248: Drug-Coated Balloon Alone Strategy to Avoid Multiple Stenting in a Patient With High Bleeding Risk

A Hybrid Approach With Stents and Drug Coated Balloons: Mainstream or Niche?

SIRONA: Sirolimus and Paclitaxel DCBs Offer Similar Patency, Function in PAD

TCT 495: The Impact of Cutting Balloon Pre-Dilation on the Outcomes of Paclitaxel Drug-Coated Balloon Treatment for Coronary In-Stent Restenosis

TCT 496: Long-term Clinical Outcomes of Drug-Coated Balloons for the Treatment of In-Stent Chronic Total Occlusions

TCT 493: Drug-Coated Balloon Angioplasty vs Plain Balloon Angioplasty in Patients With Coronary In-Stent Restenosis: A Meta-Analysis of Randomized Controlled Trials

TCT 1322: Neoatherosclerosis After Drug-Coated Balloon Treated In-Stent Restenosis

TCT 315: Acute and Long-Term Safety and Efficacy of IVUS-Guided Drug Coated Balloon Treatment for Carotid In-Stent Restenosis

TCT 569: Outcomes of Patients With Left Main Lesions Treated With Hybrid Drug-eluting Stent and Drug-coated Balloon Strategy

DCB Outdo Noncompliant Balloons in Simple Bifurcation Side Branches: DCB-BIF

TCT 39: Comparison of Clinical Outcomes Among Balloon Angioplasty, Drug-Coated Balloon, and the Second or Newer Drug-Eluting Stent

TCT 568: Drug-Coated Balloon Versus Non-Compliant Balloon Angioplasties for Side Branch After Main Vessel Stenting for True Coronary Bifurcation Lesions: The Prospective, Multicenter, Randomized, Blinded DCB-BIF Trial

TCT 441: Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease: A Systematic Review and Meta-Analysis

TCT 442: Tissue Characteristics Can Predict Clinical Outcome in Stent-Less Percutaneous Coronary Intervention With Directional Coronary Atherectomy Followed by Drug-Coated Balloon: Insights From a Histological Analysis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content